Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Meglumine market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Meglumine market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Diatrizoate Meglumine
Lothalamate Meglumine
Lodipamide Meglumine
Segmented by End User/Segment
Pharmaceuticals
Industrial
Others
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Tianma
New Hualian Pharm
Merck
Libang Healthcare Group
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Meglumine Market Status and Forecast (2016-2027) 1.3.2 Global Meglumine Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Meglumine Supply by Company 2.1 Global Meglumine Sales Volume by Company 2.2 Global Meglumine Sales Value by Company 2.3 Global Meglumine Price by Company 2.4 Meglumine Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional Meglumine Market Status by Category 3.1 Meglumine Category Introduction 3.1.1 Diatrizoate Meglumine 3.1.2 Lothalamate Meglumine 3.1.3 Lodipamide Meglumine 3.2 Global Meglumine Market by Category 3.2.1 Global Meglumine Sales Volume by Category (2016-2021) 3.2.2 Global Meglumine Sales Value by Category (2016-2021) 3.2.3 Global Meglumine Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Meglumine Market Status by End User/Segment 4.1 Meglumine Segment by End User/Segment 4.1.1 Pharmaceuticals 4.1.2 Industrial 4.1.3 Others 4.2 Global Meglumine Market by End User/Segment 4.2.1 Global Meglumine Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Meglumine Sales Value by End User/Segment (2016-2021) 4.2.3 Global Meglumine Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Meglumine Market Status by Region 5.1 Global Meglumine Market by Region 5.1.1 Global Meglumine Sales Volume by Region 5.1.2 Global Meglumine Sales Value by Region 5.2 North America Meglumine Market Status 5.3 Europe Meglumine Market Status 5.4 Asia Pacific Meglumine Market Status 5.5 Central & South America Meglumine Market Status 5.6 Middle East & Africa Meglumine Market Status6 North America Meglumine Market Status 6.1 North America Meglumine Market by Country 6.1.1 North America Meglumine Sales Volume by Country (2016-2021) 6.1.2 North America Meglumine Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Meglumine Market Status 7.1 Europe Meglumine Market by Country 7.1.1 Europe Meglumine Sales Volume by Country (2016-2021) 7.1.2 Europe Meglumine Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Meglumine Market Status 8.1 Asia Pacific Meglumine Market by Country 8.1.1 Asia Pacific Meglumine Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Meglumine Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Meglumine Market Status 9.1 Central & South America Meglumine Market by Country 9.1.1 Central & South America Meglumine Sales Volume by Country (2016-2021) 9.1.2 Central & South America Meglumine Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Meglumine Market Status 10.1 Middle East & Africa Meglumine Market by Country 10.1.1 Middle East & Africa Meglumine Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Meglumine Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Meglumine Manufacturing Cost Analysis 11.5 Meglumine Sales Channel and Distributors Analysis 11.5.1 Meglumine Sales Channel 11.5.2 Meglumine Distributors 11.6 Meglumine Downstream Major Buyers12 Global Meglumine Market Forecast by Category and by End User/Segment 12.1 Global Meglumine Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Meglumine Forecast by Category 12.2.1 Global Meglumine Sales Volume Forecast by Category 12.2.2 Global Meglumine Sales Value Forecast by Category 12.2.3 Global Meglumine Price Forecast by Category 12.3 Global Meglumine Forecast by End User/Segment 12.3.1 Global Meglumine Sales Volume Forecast by End User/Segment 12.3.2 Global Meglumine Sales Value Forecast by End User/Segment 12.3.3 Global Meglumine Price Forecast by End User/Segment13 Global Meglumine Market Forecast by Region/Country 13.1 Global Meglumine Market Forecast by Region (2022-2027) 13.1.1 Global Meglumine Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Meglumine Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Tianma 14.1.1 Company Information 14.1.2 Meglumine Product Introduction 14.1.3 Tianma Meglumine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 New Hualian Pharm 14.2.1 Company Information 14.2.2 Meglumine Product Introduction 14.2.3 New Hualian Pharm Meglumine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Merck 14.3.1 Company Information 14.3.2 Meglumine Product Introduction 14.3.3 Merck Meglumine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Libang Healthcare Group 14.4.1 Company Information 14.4.2 Meglumine Product Introduction 14.4.3 Libang Healthcare Group Meglumine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis ...15 Conclusion16 Methodology